Vapotherm (NYSE:VAPO) reported Q2 EPS of ($1.61), $0.86 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $13 million versus the consensus estimate of $18.35 million.
Vapotherm (NYSE:VAPO) reported Q2 EPS of ($1.61), $0.86 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $13 million versus the consensus estimate of $18.35 million.